Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Infants With Neuroblastoma
Protocol for Infants With Neuroblastoma Diagnosed Under the Age of One Year
4 other identifiers
interventional
120
2 countries
22
Brief Summary
RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Radiation therapy uses high-energy x-rays to kill tumor cells. Giving combination chemotherapy before surgery may make the tumor smaller and reduce the amount of normal tissue that needs to be removed. Giving chemotherapy and radiation therapy after surgery may kill any tumor cells that remain after surgery. Sometimes, the tumor may not need any treatment until it progresses. In this case, observation may be sufficient. PURPOSE: This clinical trial is studying how well giving combination chemotherapy together with surgery and radiation therapy works in treating infants with neuroblastoma.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
22 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 1992
CompletedFirst Submitted
Initial submission to the registry
February 6, 2006
CompletedFirst Posted
Study publicly available on registry
February 7, 2006
CompletedSeptember 17, 2013
December 1, 2006
February 6, 2006
September 16, 2013
Conditions
Keywords
Interventions
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
Study Sites (22)
Our Lady's Hospital for Sick Children
Dublin, 12, Ireland
Birmingham Children's Hospital
Birmingham, England, B4 6NH, United Kingdom
Institute of Child Health at University of Bristol
Bristol, England, BS2 8AE, United Kingdom
Addenbrooke's Hospital at Cambridge University Hospitals NHS Foundation Trust
Cambridge, England, CB2 2QQ, United Kingdom
Leeds Cancer Centre at St. James's University Hospital
Leeds, England, LS9 7TF, United Kingdom
Leicester Royal Infirmary
Leicester, England, LE1 5WW, United Kingdom
Royal Liverpool Children's Hospital, Alder Hey
Liverpool, England, L12 2AP, United Kingdom
Royal London Hospital
London, England, E1 1BB, United Kingdom
Great Ormond Street Hospital for Children NHS Trust
London, England, WC1N 3JH, United Kingdom
Meyerstein Institute of Oncology at University College of London Hospitals
London, England, WIT 3AA, United Kingdom
Central Manchester and Manchester Children's University Hospitals NHS Trust
Manchester, England, M27 4HA, United Kingdom
Sir James Spence Institute of Child Health
Newcastle upon Tyne, England, NE1 4LP, United Kingdom
Queen's Medical Centre
Nottingham, England, NG7 2UH, United Kingdom
Oxford Radcliffe Hospital
Oxford, England, 0X3 9DU, United Kingdom
Children's Hospital - Sheffield
Sheffield, England, S10 2TH, United Kingdom
Southampton General Hospital
Southampton, England, SO16 6YD, United Kingdom
Royal Marsden NHS Foundation Trust - Surrey
Sutton, England, SM2 5PT, United Kingdom
Royal Belfast Hospital for Sick Children
Belfast, Northern Ireland, BT12 6BE, United Kingdom
Royal Aberdeen Children's Hospital
Aberdeen, Scotland, AB25 2ZG, United Kingdom
Royal Hospital for Sick Children
Edinburgh, Scotland, EH9 1LF, United Kingdom
Royal Hospital for Sick Children
Glasgow, Scotland, G3 8SJ, United Kingdom
Childrens Hospital for Wales
Cardiff, Wales, CF14 4XW, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Penelope Brock, MD, PhD
University College London Hospitals
Mary P. Gerrard, MBChB, FRCP, FRCPCH
Children's Hospital - Sheffield
Andrew David J. Pearson, MD, FRCP, DCh
University of Newcastle Upon-Tyne
S. J. Keith Holmes, DO
St. George's Hospital
Ann Barrett
University of Glasgow
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
February 6, 2006
First Posted
February 7, 2006
Study Start
September 1, 1992
Last Updated
September 17, 2013
Record last verified: 2006-12